vs
Side-by-side financial comparison of First Seacoast Bancorp, Inc. (FSEA) and MAXCYTE, INC. (MXCT). Click either name above to swap in a different company.
MAXCYTE, INC. is the larger business by last-quarter revenue ($4.8M vs $4.0M, roughly 1.2× First Seacoast Bancorp, Inc.). First Seacoast Bancorp, Inc. runs the higher net margin — -2.4% vs -200.5%, a 198.1% gap on every dollar of revenue. On growth, First Seacoast Bancorp, Inc. posted the faster year-over-year revenue change (20.6% vs -20.9%). First Seacoast Bancorp, Inc. produced more free cash flow last quarter ($329.0K vs $-2.9M). Over the past eight quarters, First Seacoast Bancorp, Inc.'s revenue compounded faster (12.6% CAGR vs -7.4%).
Sterling Bancorp was an American regional bank holding company that owned Sterling National Bank. It merged into Webster Bank in February 2022.
MaxCyte Inc. is a global biotechnology company focused on developing cell engineering platforms and enabling technologies for cell and gene therapy advancement. Its proprietary non-viral cell modification systems are widely used by pharmaceutical, biotech and life science research entities to develop immunotherapies, gene-edited treatments and next-generation biologic drugs from preclinical research through commercialization.
FSEA vs MXCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.0M | $4.8M |
| Net Profit | $-87.0K | $-9.6M |
| Gross Margin | — | — |
| Operating Margin | -3.1% | -234.5% |
| Net Margin | -2.4% | -200.5% |
| Revenue YoY | 20.6% | -20.9% |
| Net Profit YoY | 93.8% | 9.4% |
| EPS (diluted) | $-0.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.0M | $4.8M | ||
| Q3 25 | $4.0M | $4.6M | ||
| Q2 25 | $3.9M | $5.8M | ||
| Q1 25 | $3.5M | $5.7M | ||
| Q4 24 | $3.4M | $6.1M | ||
| Q3 24 | $3.3M | $5.6M | ||
| Q2 24 | $5.9M | $5.0M | ||
| Q1 24 | $3.2M | $5.6M |
| Q4 25 | $-87.0K | $-9.6M | ||
| Q3 25 | $390.0K | $-12.4M | ||
| Q2 25 | $-545.0K | $-12.4M | ||
| Q1 25 | $-603.0K | $-10.3M | ||
| Q4 24 | $-1.4M | $-10.6M | ||
| Q3 24 | $44.0K | $-11.6M | ||
| Q2 24 | $2.0M | $-9.4M | ||
| Q1 24 | $-1.2M | $-9.5M |
| Q4 25 | -3.1% | -234.5% | ||
| Q3 25 | -5.2% | -307.4% | ||
| Q2 25 | -13.7% | -244.3% | ||
| Q1 25 | -17.9% | -214.1% | ||
| Q4 24 | -23.5% | -213.1% | ||
| Q3 24 | -17.8% | -250.4% | ||
| Q2 24 | 35.6% | -241.0% | ||
| Q1 24 | -24.8% | -219.8% |
| Q4 25 | -2.4% | -200.5% | ||
| Q3 25 | 9.8% | -269.7% | ||
| Q2 25 | -14.1% | -212.2% | ||
| Q1 25 | -17.1% | -178.7% | ||
| Q4 24 | -46.9% | -175.0% | ||
| Q3 24 | 1.3% | -205.9% | ||
| Q2 24 | 33.9% | -188.8% | ||
| Q1 24 | -36.1% | -170.6% |
| Q4 25 | $-0.04 | — | ||
| Q3 25 | $0.08 | $-0.12 | ||
| Q2 25 | $-0.13 | $-0.12 | ||
| Q1 25 | $-0.14 | — | ||
| Q4 24 | $-0.31 | — | ||
| Q3 24 | $0.01 | $-0.11 | ||
| Q2 24 | $0.42 | $-0.09 | ||
| Q1 24 | $-0.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $103.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $63.5M | $171.5M |
| Total Assets | $599.3M | $202.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $103.0M | ||
| Q3 25 | — | $105.7M | ||
| Q2 25 | — | $126.6M | ||
| Q1 25 | — | $138.3M | ||
| Q4 24 | — | $154.5M | ||
| Q3 24 | — | $153.8M | ||
| Q2 24 | — | $157.3M | ||
| Q1 24 | — | $157.5M |
| Q4 25 | $63.5M | $171.5M | ||
| Q3 25 | $63.2M | $180.3M | ||
| Q2 25 | $60.8M | $190.7M | ||
| Q1 25 | $61.2M | $199.4M | ||
| Q4 24 | $62.0M | $206.3M | ||
| Q3 24 | $65.8M | $213.3M | ||
| Q2 24 | $64.5M | $221.3M | ||
| Q1 24 | $64.7M | $226.4M |
| Q4 25 | $599.3M | $202.5M | ||
| Q3 25 | $609.6M | $213.5M | ||
| Q2 25 | $604.8M | $219.8M | ||
| Q1 25 | $592.6M | $230.0M | ||
| Q4 24 | $580.8M | $239.5M | ||
| Q3 24 | $601.8M | $248.6M | ||
| Q2 24 | $601.7M | $251.5M | ||
| Q1 24 | $576.5M | $257.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $449.0K | $-2.7M |
| Free Cash FlowOCF − Capex | $329.0K | $-2.9M |
| FCF MarginFCF / Revenue | 8.1% | -61.0% |
| Capex IntensityCapex / Revenue | 3.0% | 4.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4M | $-36.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $449.0K | $-2.7M | ||
| Q3 25 | $661.0K | $-7.5M | ||
| Q2 25 | $-151.0K | $-9.9M | ||
| Q1 25 | $573.0K | $-14.4M | ||
| Q4 24 | $-2.9M | $-7.8M | ||
| Q3 24 | $289.0K | $-4.4M | ||
| Q2 24 | $-1.4M | $-4.8M | ||
| Q1 24 | $-70.0K | $-10.6M |
| Q4 25 | $329.0K | $-2.9M | ||
| Q3 25 | $640.0K | $-7.8M | ||
| Q2 25 | $-154.0K | $-10.4M | ||
| Q1 25 | $542.0K | $-15.1M | ||
| Q4 24 | $-3.3M | $-8.0M | ||
| Q3 24 | $264.0K | $-4.8M | ||
| Q2 24 | $-1.6M | $-5.1M | ||
| Q1 24 | $-81.0K | $-11.4M |
| Q4 25 | 8.1% | -61.0% | ||
| Q3 25 | 16.0% | -168.5% | ||
| Q2 25 | -4.0% | -179.2% | ||
| Q1 25 | 15.4% | -262.3% | ||
| Q4 24 | -99.0% | -131.6% | ||
| Q3 24 | 7.9% | -85.5% | ||
| Q2 24 | -26.5% | -103.3% | ||
| Q1 24 | -2.5% | -203.6% |
| Q4 25 | 3.0% | 4.8% | ||
| Q3 25 | 0.5% | 6.5% | ||
| Q2 25 | 0.1% | 10.0% | ||
| Q1 25 | 0.9% | 11.4% | ||
| Q4 24 | 11.0% | 2.4% | ||
| Q3 24 | 0.7% | 7.2% | ||
| Q2 24 | 2.8% | 5.9% | ||
| Q1 24 | 0.3% | 14.4% |
| Q4 25 | — | — | ||
| Q3 25 | 1.69× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.57× | — | ||
| Q2 24 | -0.70× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSEA
Segment breakdown not available.
MXCT
| Products | $4.2M | 87% |
| Other | $634.0K | 13% |
